Eton Pharmaceuticals Inc
Eton Pharmaceuticals Inc (ETON) Implied Volatility Current
ETON implied volatility is 65%. IV Rank is 12%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking ETON implied volatility helps you identify when options premiums on Eton Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. Eton Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when ETON IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Eton Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ETON, tracking metrics like ETON IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ETON signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.
It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ETON implied volatility sits today versus where it has been. Our scanner ranks Eton Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in ETON IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Eton Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 18, 2026
Trade options with IV on your side
Track ETON IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→